Jiarui Wang

This study identifies Streptococcus anginosus as a gastric cancer driver that uses a chromatin remodeler to reprogram host epigenomes and promote immune evasion.

This study shows Enterococcus faecalis delivers Obg GTPase via extracellular vesicles to activate mTOR and promote HCC tumorigenesis, with clinical implications for Everolimus treatment.

This paper evaluates the safety and efficacy of SHP1705, a CRY2 activator, in preclinical models and Phase I trials, showing improved efficacy against GBM stem cells and synergistic effects with a REV-ERB agonist.